Literature DB >> 15950135

Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature.

Ahuva Grubstein1, Daniele Bendayan, Ithak Schactman, Maya Cohen, David Shitrit, Mordechai R Kramer.   

Abstract

INTRODUCTION: Smoking can cause a variety of pulmonary interstitial diseases. Pulmonary fibrosis has traditionally been considered a non-smoking-related disease. Recently, however, evidence of smoking-induced fibrosis has emerged. SUBJECTS AND METHODS: A group of eight patients from the pulmonary clinic in Rabin Medical Center with a combine presentation of fibrosis and emphysema was identified retrospectively. All patients underwent chest computed tomography and pulmonary function tests. One patient underwent lung-heart transplantation and a complete review of his lung pathology was obtained. Transbronchial biopsy was performed in 3 additional patients and echocardiography was performed to evaluate the pulmonary vasculature.
RESULTS: Upper-lobe emphysema with bulluos changes was found in all patients. In addition, a basal interstitial process was recognized, ranging from ground glass opacities to severe pulmonary fibrosis, with honeycombing. The radiological findings matched the pathological results of combined emphysema and usual interstitial pneumonia. Pulmonary function tests were also in accord, showing severe hypoxemia with mild obstruction, normal-to-mildly reduced lung volumes and a severe decrease in diffusion capacity. Most of the patients had moderate-to-severe pulmonary hypertension as well as diffuse coronary artery disease.
CONCLUSION: Our findings are in line with emerging evidence that the spectrum of interstitial damage caused by smoke includes not only Langerhans cell hystiocytosis, respiratory bronchiolitis or desquamative interstitial pneumonia but also advanced usual interstitial pneumonitis as well. We believe that in some patients smoking plays a destructive role by a variety of mechanisms and can cause emphysema, lung fibrosis as well as pulmonary vasculopathy and hypertension. Future studies are needed to define the genetics and pathophysiology of this uncommonly reported clinical syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 15950135     DOI: 10.1016/j.rmed.2004.12.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  16 in total

1.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

Review 2.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 3.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

4.  Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema.

Authors:  Matthew D Jankowich; Sharon Rounds
Journal:  Lung       Date:  2010-07-08       Impact factor: 2.584

5.  PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.

Authors:  Jami E Milam; Venkateshwar G Keshamouni; Sem H Phan; Biao Hu; Srinivasa R Gangireddy; Cory M Hogaboam; Theodore J Standiford; Victor J Thannickal; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

6.  The syndrome of combined pulmonary fibrosis and emphysema.

Authors:  Ines Zendah; Houda Gharsalli; Amel Khattab; Habib Ghedira
Journal:  Tanaffos       Date:  2011

7.  Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema.

Authors:  Saurabh Aggarwal; Israr Ahmad; Adam Lam; Matthew A Carlisle; Changzhao Li; J Michael Wells; S Vamsee Raju; Mohammad Athar; Steven M Rowe; Mark T Dransfield; Sadis Matalon
Journal:  JCI Insight       Date:  2018-11-02

8.  Centrilobular emphysema combined with pulmonary fibrosis results in improved survival.

Authors:  Nevins W Todd; Jean Jeudy; Sachin Lavania; Teri J Franks; Jeffrey R Galvin; Janaki Deepak; Edward J Britt; Sergei P Atamas
Journal:  Fibrogenesis Tissue Repair       Date:  2011-02-15

9.  Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease.

Authors:  Karina Portillo; Josep Morera
Journal:  Pulm Med       Date:  2012-02-09

Review 10.  Imaging of pulmonary emphysema: a pictorial review.

Authors:  Masashi Takahashi; Junya Fukuoka; Norihisa Nitta; Ryutaro Takazakura; Yukihiro Nagatani; Yoko Murakami; Hideji Otani; Kiyoshi Murata
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.